Vermillion Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Vermillion's estimated annual revenue is currently $2.9M per year.
- Vermillion received $10.7M in venture funding in February 2017.
- Vermillion's estimated revenue per employee is $62,340
- Vermillion's total funding is $88M.
- Vermillion has 47 Employees.
- Vermillion grew their employee count by 42% last year.
- Vermillion currently has 8 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|
|Food Safety Net...||$58.9M||380||5%||N/A||-||N/A|
|Santa Cruz Biot...||$31.9M||206||N/A||N/A||-||N/A|
|Family Tree DNA||$7.3M||47||18%||N/A||-||N/A|
What Is Vermillion?
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases. The company's initial in vitro diagnostic test, OVA1®, was the first FDA-cleared, protein-based In Vitro Diagnostic Multivariate Index Assay, and represented a new class of software-based liquid biopsy in vitro diagnostics. In March 2016 Vermillion received FDA clearance for Overa, a second generation OVA1 test with significantly improved specificity and ease of use.keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals
Number of Employees
Employee Growth %
Ministry of Transport and Civil Aviation declared Sunday that Vermillion Maldives halted ferry services in the atolls of Meemu, Faafu and Dhaalu ...
For a couple hours Monday evening in Vermillion, happiness wasn't a ... the refreshing waters of the Prentis Plunge of Vermillion in that facility's ...
1:05 PM -- A deputy responded to a report of a motorcycle abandoned near Vermillion. The motorcycle was determined to be one that was ...
|2011-02-16||$21.8M||Undisclosed||Roth Capital Partners||Article|
|2013-05-10||$31.5M||Undisclosed||Oracle Investment Management||Article|
|2014-12-24||$10.5M||Undisclosed||Oracle Investment Management||Article|
|2014-12-26||$10.5M||Undisclosed||Oracle Investment Management||Article|
Vermillion Executive Hires
|2004-03-09||William Sullivan||VP/Diagnostic Operations||Article|
|2004-07-15||Eric Fung||VP Clinical and Medical Affairs||Article|
|2005-03-15||James P. Merryweather||EVP Corp Development||Article|
|2006-06-20||Eric T. Fung||Chf Scientific Off||Article|
|2006-11-07||Debra A. Young||VP/CFO||Article|
|2007-05-16||Steve Lundy||SVP Sales/Marketing||Article|
|2010-02-03||Gail S. Page||CEO||Article|
|2010-04-20||Sandra A. Gardiner||VP/CFO||Article|
|2010-09-24||Jeffrey M. Salzman||Dir Corporate Reimbursement||Article|
|2010-10-04||Ashish Kohli||VP Corporate Strategy||Article|
|2011-09-27||Donald Munroe||Chief Scientific Officer/VP R&D||Article|
|2012-11-28||Bruce A. Huebner||Interim CEO||Article|
|2013-03-20||Bruce A. Huebner||Chairman||Article|
|2013-12-16||James T. LaFrance||Chairman||Article|
|2013-12-18||Marian E. Sacco||SVP Sales/Marketing/Chief Commercial Officer||Article|
|2014-08-15||David Jansen||VP Marketing||Article|
|2014-08-22||Holly B. Bauzon||VP Sales/Managed Markets||Article|
|2014-10-28||Valerie Palmieri||Chief Operating Officer||Article|
|2015-01-13||Laura Miller||SVP Sales/Customer Experience||Article|
|2016-11-15||Marra Francis||Chief Medical Officer||Article|
Vermillion New Location/Offices
|2011-12-20||Correlogic Systems||Assets Deal -Complete||Article|